0
edits
Changes
From Opengenome.net
no edit summary
<tr>
<td><strong> CDw76</strong></td>
<td> 110</td> <td> CD61A, GPⅡb/Ⅲa, β3 integrin chainCarbohydrate antigen</td> <td> PlateletsB cells, megakaryocytes, macrophagessubpopulation of T cells </td> <td> Integrin subunit, associates with CD41 (Gp11b/11a) or CD51 (vironectin receptor)Not known </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD77</strong></td>
<td bgcolor="#cccccc"> 140</td> <td bgcolor="#cccccc"> E-selectinPk blood group antigen, Burkitt's lymphoma antigen, (BLA), ELAM-1ceramide trihexoside (CTH), LECAM-2globotriaosylceramide (Gb3); sphingolipid antigen </td> <td bgcolor="#cccccc"> Germinal-center B cells Acutely activated endothelium, chronic inflammatory lesions of skin and synovium </td> <td bgcolor="#cccccc"> Adhesion molecule that mediates leukocyte rolling on activated endothelium at inflammatory sitesNot known </td>
</tr>
<tr>
<td><strong> CD79a</strong></td>
<td> 6540-45</td> <td> LIg-selectinα, LAM-1, LECAM-1, Leu-8, MEL-14, TQ-1MB1 </td> <td> Most peripheral-blood B cells, T cells, monocytes, granulocytes, NK cells bone-marrow lymphocytes and myeloid cells, thymocytes</td> <td> Adhesion molecule that mediates lymphocyte homing Component of B-cell antigen receptor analogous to high endothelial venules of peripheral lymphoid tissue CD3, required for cell-surface expression and leukocyte rolling on activated endothelium at inflammatory sitessignal transduction </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD79b</strong></td>
<td bgcolor="#cccccc"> 12037</td> <td bgcolor="#cccccc"> P-selectinB29, granule membrane proteinIg-140 (GMP-140), platelet activation-dependent granule-external membrane protein (PADGEM)β </td> <td bgcolor="#cccccc"> Endothelium, platelets, megakaryocytesB cells </td> <td bgcolor="#cccccc"> Interaction with PSGLComponent of B-1 cell antigen receptor analogous to mediate tethering and rolling of leukocytes on the CE3, required for cell-surface of activated endothelial cells, the first step in leukocyte extravasation expression and migration toward sites of inflammationsignal transduction </td>
</tr>
<tr>
<td><strong> CD80</strong></td>
<td> 40-60</td> <td> B7, B7.1, BB1 LIMP, MLA1, PTLGP40, gp55, granulophysin lysosomal-membrane-associated glycoprotein 3 (LAMP-3), melanoma-associated antigen (ME491), neuroglandular antigen (NGA)</td> <td> Platelets, endothelium, degranulated neutrophils, monocytes, Activated B and T cells; macrophages endothelium </td> <td> Not knownCo-stimulation of T-cell activation with CD86 </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD81</strong></td>
<td bgcolor="#cccccc"> 7226</td> <td bgcolor="#cccccc"> FcTarget for anti-proliferative antigen-1 (TAPA-1)&gammanbsp;\RI, FCRI</td> <td bgcolor="#cccccc"> MonocytesBroadly expressed on hematopoeitic cells; expressed by endothelial and epithelial cells; absent from erythrocytes, macrophagesplatelets, bood and germinal-center dendritic cells, PMN activated by IFN-neutrophils&gammanbsp; or G-CSF, early myeloid-lineage cells</td> <td bgcolor="#cccccc"> Phagocytosis: receptorMember of CD19/CD21/Leu-13 signal-mediated endocytosis of IgGtransduction complex, the B-antigen complexes; antigen capture for presentation to T cells; antibodycell co-dependent cellular cytotoxicity; mediator of release by some cells of cytokines and reactive oxygen intermediatesreceptor</td>
</tr>
<tr>
<td><strong> CD82</strong></td>
<td> 45-90</td> <td> Ceramide-dodecasaccharide4F9, C33, IA4, KAI1, VIM-2; glycolipidR2 </td> <td> Myeloid Activated/differentiated hematopoeitic cells </td> <td> Not knownSignal transduction: may induce T-cell spreading and pseudopod formation, modulate T-cell proliferation, and provide co-stimulatory signals for cytokine production; possible role in activation of monocytes </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD83</strong></td>
<td bgcolor="#cccccc"> 43</td> <td bgcolor="#cccccc"> Sialylated-CD65, VIM-2; carbohydrateHB15 </td> <td bgcolor="#cccccc"> GranulocytesDendritic cells, B cells, monocytesLangerhans cells </td> <td bgcolor="#cccccc"> Possible involvement with phagocytosis and Ca 2+ influxNot known </td>
</tr>
<tr>
<td><strong> CD84</strong></td>
<td> 160-18073</td> <td> NCA-160, biliary glycoprotein (BGP)GR6 </td> <td> GranulocytesMonocytes, epithelial platelets, circulating B cells </td> <td> Adhesion molecule; receptor for <em>Neisseria gonorrheae</em> and <em>N. meningitidis</em>; trigger of neutrophil activationNot known </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD85</strong></td>
<td bgcolor="#cccccc"> 95-100110</td> <td bgcolor="#cccccc"> CD67, CGM6, NCA-95GR4 </td> <td bgcolor="#cccccc"> GranulocytesPlasma cells, mantle-zone and germinal-center B cells, subpopulation of peripheral-blood NK cells </td> <td bgcolor="#cccccc"> Adhesion moleculePossible role in T-cell activation in peripheral trigger of neutrophil activationblood </td>
</tr>
<tr>
<td><strong> CD86</strong></td>
<td> 9080</td> <td> NCA, NCA-50/90B7.2 </td> <td> GranulocytesDendritic cells, epithelial memory B cells, germinal-center B cells, monocytes </td> <td> Adhesion Major T cell costimulatory molecule; trigger of neutrophil activation, interacting with CD28 (stimulatory) and CTLA4 (inhibitory) </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD87</strong></td>
<td bgcolor="#cccccc"> 3041-68, 35-39</td> <td bgcolor="#cccccc"> CGM1Urokinase plasminogen activator receptor (uPAR) </td> <td bgcolor="#cccccc"> GranulocytesT cells, NK cells, monocytes, neutrophils; non-hematopoeitic cells such as vascular endothelial cells, fibroblasts, smooth muscle cells, keratinocytes, placental trophoblasts, hepatocytes </td> <td bgcolor="#cccccc"> UnclearReceptor for uPA, which can convert plasminogen to plasmin; possible role in β receptor for <em>Neisseria gonorrheae 2 integrin-dependent adherence and N. meningitidis</em>chemotaxis</td>
</tr>
<tr>
<td><strong> CD88</strong></td>
<td> 180-20043</td> <td> Carcinoembryonic antigen (CEA) C5a receptor, C5aR</td> <td> Epithelial Granulocytes, monocytes, dendritic cells </td> <td> UnclearC5a-mediated inflammation; possible adhesion moleculeactivation of granulocytes </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD89</strong></td>
<td bgcolor="#cccccc"> 5445-7270, 55-75, 70-100, 50-65</td> <td bgcolor="#cccccc"> PregnancyFcα-specific b1 glycoprotein, SP-1, pregnancy-specific glycoprotein receptor R (PSG)Fc alpha;-R), IgA Fc receptor, IgA receptor</td> <td bgcolor="#cccccc"> Fetal liverMyeloid-lineage cells from promyelocytes to neutrophils and from promonocyte to monocytes; produced in placenta activated eosinophils, alveolar and releasedsplenic macrophages </td> <td bgcolor="#cccccc"> Unclear; possible involvement in immune regulation and protection Induction of phagocytosis, degranulation, respiratory burst, killing of fetus from maternal immune system; necessary for successful pregnancymicroorganisms </td>
</tr>
<tr>
<td><strong> CD90</strong></td>
<td> 11025-35</td> <td> gp110, macrosialinThy-1 </td> <td> Monocytes, macrophages, dendritic Hematopoeitic stem cells, neutrophilsthymocytes, basophils, mast cells, myeloid progenitor cells, subset of CD34+ hematopoeitic progenitor cells, activated peripheral T cells, some peropheral-blood B cellshuman node HEV endothelium </td> <td> Not knownPossible involvement in lymphocyte co-stimulation; possible inhibition of proliferation and differentiation of hematopoeitic stem cells </td>
</tr>
</tbody>
</table>